TrialBMC infectious diseases2020

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial.

Naser Gharebaghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.